Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Jody V. Vykoukal

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7797-627X; OpenAlex author ID A5040696818, A5085335016. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
64
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 14

  1. Assessment of impending pancreatic cancer in a cohort of new onset diabetes on basis of biomarker trajectory Co-author DOI 10.64898/2026.08.06.26359908↗
  2. KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adeno… Co-author DOI 10.64898/2026.10.05.756824↗
  3. Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing. Co-author DOI 10.1016/j.canlet.2025.217450↗
  4. Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progress… Co-author DOI 10.1158/1078-0432.ccr-24-2931↗
  5. Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. Co-author DOI 10.1093/clinchem/hvad186↗
  6. A blood-based metabolomic signature predictive of risk for pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2023.101194↗
  7. Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an ea… Co-author DOI 10.1101/2023.08.14.553002↗
  8. CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. Co-author DOI 10.1016/j.molmet.2021.101426↗
  9. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Co-author DOI 10.1053/j.gastro.2020.11.052↗
  10. CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. Co-author DOI 10.1200/po.19.00330↗
  11. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. First author DOI 10.1038/s41467-018-08109-6↗
  12. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy126↗
  13. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident st… Co-author DOI 10.18632/oncotarget.7066↗
  14. RSPO2 Enhances Canonical Wnt Signaling to Confer Stemness-Associated Traits to Susceptible Pancreatic Cancer Cells. Last author DOI 10.1158/0008-5472.can-14-1327↗

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Samir Hanash · 12 shared papers, 2019–2026 · strength 1.74
  2. Anirban Maitra · 12 shared papers, 2019–2026 · strength 1.74
  3. Johannes Francois Fahrmann · 11 shared papers, 2019–2026 · strength 1.67
  4. Ehsan Irajizad · 10 shared papers, 2020–2026 · strength 1.60
  5. Michele Yip-Schneider · 6 shared papers, 2019–2025 · strength 0.91
  6. Jianjun Zhang · 6 shared papers, 2019–2025 · strength 0.91
  7. Ricardo A. Léon-Letelier · 4 shared papers, 2023–2026 · strength 0.73
  8. Christian Max Schmidt · 5 shared papers, 2019–2025 · strength 0.68
  9. Yihui Chen · 4 shared papers, 2022–2026 · strength 0.65
  10. Ziding Feng · 4 shared papers, 2019–2026 · strength 0.45
  11. Eugene Jon Koay · 2 shared papers, 2026 · strength 0.44
  12. Florencia M. McAllister · 2 shared papers, 2026 · strength 0.44
  13. Brian Matthew Wolpin · 3 shared papers, 2021–2026 · strength 0.43
  14. Riccardo Ballarò · 2 shared papers, 2025–2026 · strength 0.40
  15. Michela Capello · 4 shared papers, 2019–2022 · strength 0.33
  16. Marta Sans · 2 shared papers, 2023 · strength 0.26
  17. Matthew H. G. Katz · 3 shared papers, 2019–2022 · strength 0.26
  18. Matthew R. Young · 1 shared paper, 2026 · strength 0.23
  19. Suresh T. Chari · 1 shared paper, 2026 · strength 0.23
  20. Bechien U. Wu · 1 shared paper, 2026 · strength 0.23
  21. Phil A. Hart · 1 shared paper, 2026 · strength 0.23
  22. Christopher M. Schmidt · 1 shared paper, 2025 · strength 0.23
  23. Ana Babić · 2 shared papers, 2021–2023 · strength 0.22
  24. Andrea J. Bullock · 2 shared papers, 2021–2023 · strength 0.22
  25. Thomas E. Clancy · 2 shared papers, 2021–2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.